Home Page Twitter Facebook Linked-In YouTube Home Page Join List-Serve Privacy Policy ADAP Advocacy Association

About ADAPs About Us Contact Us Events Publications Media Clips Press Room Support

About giving more than just a handfull of hope...aaa+

HEAR. HELP. HEAL. HOPE.

The ADAP Advocacy Association (aaa+®) mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. aaa+® works with advocates, community, health care, government, patients, pharmaceutical companies and other stakeholders to assure that access to services recognize and afford persons living with HIV/AIDS to enjoy a healthy life.

aaa+® is the only national grassroots organization focused exclusively on ADAPs and ensuring that there are adequate resources nationwide to eliminate or prevent waiting lists for services. Our purpose is to better engage people living with HIV/AIDS by providing a platform whereby they can offer their personal experiences, challenges, knowledge, insight and solutions to solving this perpetual problem.

Breaking News

ADAP Advocacy Association Issues Call for Nominations for its 2015 Annual ADAP Leadership Awards

Awards to recognize leaders who are working to improve access to care and treatment

WASHINGTON, D.C. (March 5, 2015) - The ADAP Advocacy Association, also known as aaa+®, today opened nominations for its 2015 Annual ADAP Leadership Awards. The awards recognize individual, community, government and corporate leaders who are working to improve access to care and treatment under the AIDS Drug Assistance Programs. [PDF | DOC]

CLICK HERE to submit nomination.

ADAP Blog

Need for National Data on HCV Prevention, Care, and Treatment to Impact
the National HCV Epidemic

By: Marissa Tonelli, Senior Manager, HealthHCV Initiative

The Centers for Disease Control and Prevention (CDC) estimates 3.2 million people in the United States are living with chronic hepatitis C infection; 80% of whom will develop chronic liver disease, close to a quarter of whom will go on to develop cirrhosis; and, about 5% of whom will die as a result of chronic HCV infection. These continue to be estimates as a result of limited national data and the disparate nature of the datasets, which have been barriers to fully understanding the extent and details of the national HCV epidemic. Without a fully resourced, national hepatitis surveillance system, clinical providers and public health officials rely on limited data to inform decision-making.

According to the European Association for the Study of Liver Disease (EASL) Recommendations on Treatment of Hep C, inaccurate data, as well as lack of data for specific sub-populations, is an element hindering the design of effective public health interventions and limits the development of provider guidelines. Collection and analysis of national data related to HCV prevention, care, and treatment is essential to informing effective public health and clinical interventions to impact the epidemic.

CLICK HERE to read more.

ADAP Update

ADAPs with Waiting Lists
(35 individuals in 1 state(s) on the ADAP Waiting List as of July 28, 2014)
Source: The ADAP Watch, National Alliance of State & Territorial AIDS Directors (NASTAD).

  • Eleven ADAPs have had cost-containment measures in place since April 1, 2013 (reported as of July 15, 2014).
  • No ADAPs currently anticipate additional cost-containment measures prior to March 31, 2015.

» Go to the ADAP Watch

Support Our Scholarship Fund

ADAP Directory

Home · Join List-Serve · About ADAPs · About Us · Blog · Events · Publications
Media Clips · Press Room · Support · Privacy · Contact Us